Françoise Gellibert

1.8k citations
8 papers · 730 indexed · h-index 8
Topics
TGF-β signaling in diseases (5 papers)Liver physiology and pathology (2 papers)Bone Metabolism and Diseases (2 papers)

In The Last Decade

Françoise Gellibert

8 papers receiving 719 citations

Peers

Françoise Gellibert
Comparison fields: 5 of 78
  • Molecular Biology 462
  • Oncology 157
  • Nephrology 80
  • Pulmonary and Respiratory Medicine 77
  • Hepatology 69
Replace Yang Dong with:
Yang Dong China
Federica Rascio Italy
Anne‐Charlotte de Gouville France
Federica Spadaccino Italy
Brad Hirakawa United States
Graziella Malaponte Italy
Meghan E. McMullen United States
Fernando Cordera Mexico
Weifan Weng United States
F. Mihaimeed United Kingdom
Françoise Gellibert relative to Yang Dong China Yang Dong's profile →
Citations per field
00.5×3.8×
Yang Dong · 1×
Citations per year

Countries citing papers authored by Françoise Gellibert

Since Specialization
Citations

This map shows the geographic impact of Françoise Gellibert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Gellibert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Gellibert more than expected).

Fields of papers citing papers by Françoise Gellibert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Gellibert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Gellibert. The network helps show where Françoise Gellibert may publish in the future.

Co-authorship network of co-authors of Françoise Gellibert

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Gellibert. A scholar is included among the top collaborators of Françoise Gellibert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Gellibert. Françoise Gellibert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 36
2 26
3 64
4 177
5 32
6 86
7 143
8 166

About Françoise Gellibert

Françoise Gellibert is a scholar working on Hepatology, Hematology and Nephrology, having authored 8 papers that have together received 730 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (5 papers), Liver physiology and pathology (2 papers) and Bone Metabolism and Diseases (2 papers). The work is most often cited by research in Nephrology (80 citations), Hepatology (69 citations) and Molecular Biology (462 citations). Françoise Gellibert has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Stéphane Huet, Gaël Krysa, Anne‐Charlotte de Gouville, Eugene T. Grygielko, Nicholas J. Laping, Alain Laroze, Martijn Deckers, Midory Thorikay, Maarten van Dinther and James M. Woolven. Their work appears in journals such as Kidney International, Journal of Medicinal Chemistry and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026